CN102657737A - Medicament for treating acute gouty arthritis - Google Patents

Medicament for treating acute gouty arthritis Download PDF

Info

Publication number
CN102657737A
CN102657737A CN2012100755924A CN201210075592A CN102657737A CN 102657737 A CN102657737 A CN 102657737A CN 2012100755924 A CN2012100755924 A CN 2012100755924A CN 201210075592 A CN201210075592 A CN 201210075592A CN 102657737 A CN102657737 A CN 102657737A
Authority
CN
China
Prior art keywords
parts
medicament
gouty arthritis
radix
acute gouty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012100755924A
Other languages
Chinese (zh)
Other versions
CN102657737B (en
Inventor
潘�清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangyin Tianjiang Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201210075592 priority Critical patent/CN102657737B/en
Publication of CN102657737A publication Critical patent/CN102657737A/en
Application granted granted Critical
Publication of CN102657737B publication Critical patent/CN102657737B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicament for treating acute gouty arthritis which is prepared from the following materials by weight: 10 to 20 parts of glycyrrhiza, 20 to 30 parts of Fructus Physalis, 10 to 30 parts of angelica root, 20 to 50 parts of net cliffbean, 5 to 15 parts of Salvia, 5 to 15 parts of epimedium, 5 to 10 parts of frankincense, 10 to 20 parts of manyprickle acanthopanax root and 10 to 20 parts of polygonum cuspidatum. The medicament for treating acute gouty arthritis described in this invention uses natural medicines, and has advantages of rapid effect, good efficacy and no side-effect.

Description

A kind of medicament of treating acute gouty arthritis
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicament of treating acute gouty arthritis.
Background technology
Acute gouty arthritis is long-term crash cry of certain animals metabolism disorder, one group of disease due to urate excretion reduces.The clinical manifestation onset is hurried, and how to open up the toe joint red and swollen heat pain with first is first symptom, in 1 day, peaks, and blood uric acid generally raises.
At present, the needs for the medicine of treating acute gouty arthritis constantly strengthen.
Summary of the invention
The purpose of this invention is to provide a kind of medicament of treating acute gouty arthritis.
In order to realize the object of the invention; The present invention provides a kind of medicament of treating acute gouty arthritis, and it is to be processed by weight by following bulk drugs: Radix Glycyrrhizae 10-20 part, Calyx seu Fructus physalis 20-30 part, Radix Angelicae Dahuricae 10-30 part, Caulis Spatholobi 20-50 part, Radix Salviae Miltiorrhizae 5-15 part, Herba Epimedii 5-15 part, Olibanum 5-10 part, Radix Et Caulis Acanthopanacis Senticosi 10-20 part and Rhizoma Polygoni Cuspidati 10-20 part.
Preferably, it is to be processed by weight by following bulk drugs: 15 parts of 15 parts in Radix Glycyrrhizae, 25 parts of Calyx seu Fructus physaliss, 20 parts of the Radixs Angelicae Dahuricae, 30 parts of Caulis Spatholobis, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts of Herba Epimedii, 8 parts of Olibanums, 15 parts of Radix Et Caulis Acanthopanacis Senticosis and Rhizoma Polygoni Cuspidati.
Preferably, said medicament is tablet, dispersible tablet, instant, powder or granule.
The medicament of treatment acute gouty arthritis of the present invention uses natural drug, so its advantage that has instant effect, good effect, has no side effect.
The specific embodiment
Below description through the specific embodiment the present invention is described further; But this is not to be limitation of the present invention; Those skilled in the art are according to basic thought of the present invention; Can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Extracting liquorice 150 grams, Calyx seu Fructus physalis 250 grams, the Radix Angelicae Dahuricae 200 grams, Caulis Spatholobi 300 grams, Radix Salviae Miltiorrhizae 100 grams, Herba Epimedii 100 grams, Olibanum 80 grams, Radix Et Caulis Acanthopanacis Senticosi 150 grams and Rhizoma Polygoni Cuspidati 150 grams; Pulverize, cross 100 mesh sieves, add sucrose 300 grams then; Mixing, packing into promptly gets in 100 bags.
Experimental example
Diagnostic criteria
With reference to the diagnostic criteria that American Rheumatism Association 1997 works out, possess 6 persons in 12 of following clinical, laboratory and the X ray examinations: 1) arthritis outbreak more than 1 time; 2) inflammation shows in 1 day and peaks; 3) simple joint morbidity; 4) redness and swelling of joints; 5) first ring toe joint pain or the swelling; 6) the first bad toe joint is involved in one-sided outbreak; 7) osteoarthrosis of staggering is involved in one-sided outbreak; 8) suspicious tophus; 9) hyperuricemia; 10) X-ray film shows joint asymmetry swelling; 11) X-ray film shows that the cortical bone of not accompanying sclerotin the to soak into appearance of giving a farfetched interpretation is bright damaged; 12) arthritis is between stage of attack, and the joint fluid biological culture is negative.
Choose patient's 50 examples that meet above-mentioned standard, wherein male 25 examples, women 25 examples; 35~71 years old age, average 52 years old.
Use the powder that makes among the embodiment 1 to treat, wherein one day 2 times, each one bag, treating January is a course of treatment.
Curative effect determinate standard
With reference to " clinical disease diagnosis according to cure improvement standard " (The General Logistics Department of PLA's Ministry of Public Health, clinical disease diagnosis is according to curing improvement standard [M]. Beijing: the People's Medical Officer Press, the standard in 1987:715.) is drafted.Cure: symptom complete obiteration, blood uric acid recover normal.Produce effects: transference cure, blood uric acid recover normal or obviously reduce.Effectively: remission, blood uric acid descends to some extent.Invalid: symptom does not have improvement, the blood uric acid no change.
Through the observation of a course of treatment is arranged, find that whole patients all meet the standard of healing.
After treating a course of treatment, all the patient is followed up a case by regular visits to weekly, continue half a year, find the sign of recurrence.

Claims (3)

1. medicament of treating acute gouty arthritis; It is characterized in that it is to be processed by weight by following bulk drugs: Radix Glycyrrhizae 10-20 part, Calyx seu Fructus physalis 20-30 part, Radix Angelicae Dahuricae 10-30 part, Caulis Spatholobi 20-50 part, Radix Salviae Miltiorrhizae 5-15 part, Herba Epimedii 5-15 part, Olibanum 5-10 part, Radix Et Caulis Acanthopanacis Senticosi 10-20 part and Rhizoma Polygoni Cuspidati 10-20 part.
2. the medicament of treatment acute gouty arthritis according to claim 1; It is characterized in that it is to be processed by weight by following bulk drugs: 15 parts of 15 parts in Radix Glycyrrhizae, 25 parts of Calyx seu Fructus physaliss, 20 parts of the Radixs Angelicae Dahuricae, 30 parts of Caulis Spatholobis, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts of Herba Epimedii, 8 parts of Olibanums, 15 parts of Radix Et Caulis Acanthopanacis Senticosis and Rhizoma Polygoni Cuspidati.
3. the medicament of treatment acute gouty arthritis according to claim 1 and 2 is characterized in that, said medicament is tablet, dispersible tablet, instant, powder or granule.
CN 201210075592 2012-03-21 2012-03-21 Medicament for treating acute gouty arthritis Expired - Fee Related CN102657737B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210075592 CN102657737B (en) 2012-03-21 2012-03-21 Medicament for treating acute gouty arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210075592 CN102657737B (en) 2012-03-21 2012-03-21 Medicament for treating acute gouty arthritis

Publications (2)

Publication Number Publication Date
CN102657737A true CN102657737A (en) 2012-09-12
CN102657737B CN102657737B (en) 2013-10-02

Family

ID=46767405

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210075592 Expired - Fee Related CN102657737B (en) 2012-03-21 2012-03-21 Medicament for treating acute gouty arthritis

Country Status (1)

Country Link
CN (1) CN102657737B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104274538A (en) * 2014-09-23 2015-01-14 苏州市天灵中药饮片有限公司 Traditional Chinese medicine extract for treating gout and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1413638A (en) * 2002-09-08 2003-04-30 许忠文 Chinese medicine composite for treating gouty arthropathy
CN1814215A (en) * 2005-12-06 2006-08-09 四川亚泰药业有限责任公司 Medicine for treating gout and gout arthritis
CN101019972A (en) * 2007-03-14 2007-08-22 刘树平 Liquid Chinese medicine for treating rheumatic arthritis and rheumatoil arthritis
CN101185730A (en) * 2006-11-21 2008-05-28 申海莉 Pain-relieving mixture for treating gouty arthritis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1413638A (en) * 2002-09-08 2003-04-30 许忠文 Chinese medicine composite for treating gouty arthropathy
CN1814215A (en) * 2005-12-06 2006-08-09 四川亚泰药业有限责任公司 Medicine for treating gout and gout arthritis
CN101185730A (en) * 2006-11-21 2008-05-28 申海莉 Pain-relieving mixture for treating gouty arthritis
CN101019972A (en) * 2007-03-14 2007-08-22 刘树平 Liquid Chinese medicine for treating rheumatic arthritis and rheumatoil arthritis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104274538A (en) * 2014-09-23 2015-01-14 苏州市天灵中药饮片有限公司 Traditional Chinese medicine extract for treating gout and preparation method thereof

Also Published As

Publication number Publication date
CN102657737B (en) 2013-10-02

Similar Documents

Publication Publication Date Title
CN101530579B (en) A pharmaceutical composition for soothing the nerves
CN101912567B (en) Chinese medicinal prescription for treating chronic myocarditis
CN102657737B (en) Medicament for treating acute gouty arthritis
CN102657706A (en) Infantile anti-cold umbilical therapeutic ointment
CN103341037B (en) Traditional Chinese medicine composition for treating azoospermia
CN101284108B (en) Traditional Chinese medicine combination for curing lumbar disease
CN103948878B (en) A kind of Chinese medicine composition for the treatment of osteopathia
CN102697999A (en) Externally applied Chinese medicine for treating rheumatism
CN103169855A (en) Drug composition for treating chronic heart failure
CN102302744B (en) Chinese medicinal preparation for treating chronic cholecystitis
CN102552511B (en) Medicament for treating diarrhea
CN101647980B (en) Traditional Chinese medicine paste for expelling wind, removing dampness and promoting blood circulation to stop pain
CN104474184B (en) A kind of drug for treating cough after common cold
CN100534496C (en) Chinese medicine for treating ischemic necrosis of femoral head
CN103301368A (en) Medicament for treating hyperactivity
CN104547851B (en) One treats hypertensive medicine
CN104162105A (en) Medicine for treating acute mastitis
CN103830684B (en) One treats menorrheal pharmaceutical composition and application thereof
CN103341126A (en) Chinese medicine composite for treating chronic gastritis and preparation method thereof
CN102657836B (en) Medicine composition used for treating insomnia
CN102895580B (en) Pulse invigorating and kidney tonifying medicament
CN102764325B (en) Chinese medicinal composition for dispelling rheumatism and relieving pain
CN101979073A (en) Medicament for soothing liver and regulating Qi
CN105147971A (en) Traditional Chinese medicine preparation for treating infantile suppurative tonsillitis
CN104888032B (en) Diarrhea applies

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: TIANJIANG PHARMACEUTICAL INDUSTRY CO., LTD., JIANG

Free format text: FORMER OWNER: PAN QING

Effective date: 20141222

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 272049 JINING, SHANDONG PROVINCE TO: 214400 WUXI, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20141222

Address after: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8

Patentee after: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin

Address before: 272049 Department of pharmacy, Jining Second People's Hospital,, 107 Hongxing Road East, Jining, Shandong, Shandong

Patentee before: Pan Qing

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131002

Termination date: 20170321